Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
GSK
GSK
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
GSK News
GSK's Exdensur Approved in China for Severe Asthma Treatment
20h ago
NASDAQ.COM
Pharma Stocks Pfizer and GSK Provide Safe Investment Options Amid Market Uncertainty: Charts
13h ago
Barron's
Stock Futures Edge Higher Amid Geopolitical Tensions and Energy Market Pressures
17h ago
seekingalpha
Vaccines Become a Backburner Issue for Trump Administration Ahead of Midterms
3d ago
seekingalpha
Novartis Plans $2 Billion Acquisition of Excellergy for Allergy Treatment
3d ago
CNBC
GSK Seeks EMA Approval for Bepirovirsen in Chronic Hepatitis B Treatment
3d ago
NASDAQ.COM
Clover Biopharmaceuticals Reports Phase I Trial Results for RSV Vaccine
6d ago
NASDAQ.COM
Pfizer Seeks Approval for Lyme Disease Vaccine Despite Trial Setback
Mar 23 2026
CNBC
Pfizer Seeks Regulatory Approval for Lyme Disease Vaccine
Mar 23 2026
Newsfilter
REGENXBIO INC ANNOUNCES SETTLEMENT AND RELEASE AGREEMENT WITH GLAXOSMITHKLINE DATED MARCH 18, 2026 - SEC FILING
Mar 20 2026
moomoo
GSK's Lynavoy Receives FDA Approval for Cholestatic Pruritus
Mar 19 2026
seekingalpha
Judge Blocks Major Changes to Childhood Vaccination Guidelines
Mar 16 2026
seekingalpha
Amgen and GSK Join TrumpRx Drug Sales Platform
Mar 14 2026
seekingalpha
GSK and Amgen Expand TrumpRx with New Medications - Fox Business
Mar 13 2026
moomoo
GSK Expands AREXVY Vaccine Indication for Younger Adults
Mar 13 2026
Newsfilter
GSK's RSV Vaccine Receives FDA Approval for Expanded Age Indication
Mar 13 2026
NASDAQ.COM
Show More News
